Analyst Reco. Caribou Biosciences, Inc.

Equities

CRBU

US1420381089

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
1.95 ^USD	-6.70%		-32.29%	-65.97%

Jun. 04	US Equities Markets Close Mixed Monday as US Manufacturing Contracts	MT
Jun. 04	HC Wainwright Adjusts Price Target on Caribou Biosciences to $9 From $24, Maintains Buy Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Caribou Biosciences to $9 From $24, Maintains Buy Rating	Jun. 04	MT
Caribou Biosciences Shares Fall After Evercore ISI Downgrade on Post Clinical Trial Results	Jun. 03	MT
Evercore ISI Downgrades Caribou Biosciences to In-Line Rating With $3 Price Target	Jun. 03	MT
Truist Adjusts Price Target on Caribou Biosciences to $19 From $21, Maintains Buy Rating	May. 09	MT
HC Wainwright Adjusts Caribou Biosciences Price Target to $24 From $23, Maintains Buy Rating	Mar. 19	MT
Cantor Fitzgerald Initiates Caribou Biosciences at Neutral Rating	Nov. 08	MT
HC Wainwright Adjusts Caribou Biosciences Price Target to $23 From $25, Maintains Buy Rating	23-07-26	MT
HC Wainwright Adjusts Price Target on Caribou Biosciences to $26 From $27, Maintains Buy Rating	23-03-14	MT
Oppenheimer Adjusts Caribou Biosciences Price Target to $32 From $36, Maintains Outperform Rating	23-03-10	MT
Citigroup Trims Price Target on Caribou Biosciences to $38 From $39, Reiterates Buy Rating	22-08-29	MT
HC Wainwright Adjusts Caribou Biosciences' Price Target to $27 from $28, Keeps Buy Rating	22-08-18	MT
RBC Cuts Price Target on Caribou Biosciences to $19 From $22, Maintains Outperform Rating, Speculative Risk Qualifier	22-08-10	MT
Citigroup Adjusts Price Target on Caribou Biosciences to Street-High $39 From $29, Reiterates Buy Rating	22-05-13	MT
SVB Securities Raises Caribou Biosciences' Price Target to $34 From $30, Maintains Outperform Rating	22-05-12	MT
SVB Securities Raises Caribou Biosciences Price Target to $30 From $29, Outperform Rating Kept	22-05-10	MT
SVB Leerink Adjusts Caribou Biosciences' Price Target to $29 from $32, Keeps Outperform Rating	22-03-22	MT
RBC Initiates Caribou Biosciences at Outperform-Speculative Risk, Sees 'Attractive Entry Point' Ahead of Clinical Data, Sets Price Target at $22	22-02-18	MT
Brookline Capital Starts Caribou Biosciences at Buy with $19 Price Target	22-02-14	MT
Oppenheimer Initiates Caribou Biosciences With Outperform Rating, $36 Price Target	21-12-01	MT
HC Wainwright Starts Caribou Biosciences at Buy With $28 Price Target	21-11-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Caribou Biosciences, Inc.

Equities

CRBU

US1420381089

Analyst Reco.

Filters